首页> 外文期刊>BMC Anesthesiology >Clinical application of a novel endoscopic mask: a randomized controlled, multi-center trial in patients undergoing awake fiberoptic bronchoscopic intubation
【24h】

Clinical application of a novel endoscopic mask: a randomized controlled, multi-center trial in patients undergoing awake fiberoptic bronchoscopic intubation

机译:新型内窥镜面罩的临床应用:接受清醒纤维支气管镜插管的患者的随机对照,多中心试验

获取原文
       

摘要

Background Awake fiberoptic bronchoscopic tracheal intubation is usually regarded as an effective method in the management of predicted difficult airway. Hypoxia during awake nasal fiberoptic bronchoscopic intubation leads to discontinuation of the procedure, prolonged manipulation time and increased risk of severe complications. The main aim of the study was to test whether the novel endoscopic mask is helpful for hypoxia during the intubation. Methods This was a randomized, controlled, multi-center study. 55 patients were recruited, but one patient was lost to follow-up. Finally, 54 patients (19 man and 35 women) were analyzed. After entering the operating room, nasal catheter oxygen-providing was given in the control group, and the treatment group received endoscopic mask oxygen-providing, with a flow rate of 3?L/min, lasting into the end of the intubation. Primary outcomes included mean arterial pressure, heart rate, minimum pulse oxygen saturation and incidence of pulse oxygen saturation ≤ 90%. Secondary outcomes included number of intubation attempts and time to intubation. All outcomes were finally measured. Results Minimum pulse oxygen saturation during awake nasal fiberoptic bronchoscopic tracheal intubation was significantly higher in the endoscopic mask intubation group (91.7%?±?4.7%) than that the nasal catheter intubation group (87.6%?±?8.2%, P =?0.031. Furthermore, the incidence of pulse oxygen saturation ≤ 90% was significantly lower in the endoscopic mask intubation group (20.0%, 5/25) than that in the nasal catheter intubation group (51.7%, 15/29, P =?0.037). But mean arterial pressure of during intubation was significantly higher in the endoscopic mask group (100.0?±?13.3 vs 90.3?±?21.8, P =?0.049). In addition, there were no differences in the number of intubation attempts ( P =?0.45) or time to intubation between the two groups ( P =?0.38). Conclusions The endoscopic mask was safely used in awake fiberoptic bronchoscopic tracheal intubation, with advantages of stable blood pressure and potential prevention of desaturation. Beginners for the intubation procedure and patients at high risk of hypoxia could benefit from the use of the endoscopic mask. Trial registration Trial registration: www.chictr.org.cn . Registration No.: ChiCTR-TRC-13004086. Date of Registration: 8th, Sep, 2013.
机译:背景技术清醒的纤维支气管镜气管插管通常被认为是治疗困难气道的有效方法。清醒的鼻纤维支气管镜插管时缺氧会导致手术中断,延长操作时间并增加发生严重并发症的风险。该研究的主要目的是测试新型内窥镜面罩是否有助于插管过程中的缺氧。方法这是一项随机,对照,多中心研究。招募了55名患者,但有1名患者失访。最后,分析了54例患者(男19例,女35例)。进入手术室后,在对照组中给鼻导管供氧,治疗组接受内窥镜面罩供氧,流量为3?L / min,一直持续到插管结束。主要结局包括平均动脉压,心率,最小脉搏血氧饱和度和脉搏血氧饱和度≤90%。次要结果包括插管尝试次数和插管时间。最终评估了所有结果。结果清醒的鼻纤维支气管镜气管插管时的最低脉冲氧饱和度显着高于鼻内镜插管组(91.7%?±?4.7%),高于鼻导管插管组(87.6%?±?8.2%,P =?0.031此外,内镜面罩插管组的脉搏血氧饱和度≤90%的发生率(20.0%,5/25)显着低于鼻导管插管组(51.7%,15/29,P =?0.037)。但是,内窥镜面罩组的插管过程中的平均动脉压明显更高(100.0±±13.3 vs 90.3±±21.8,P =±0.049)。此外,插管尝试次数没有差异(P =≥0.45)或两组之间的插管时间(P =≤0.38)结论内镜面罩可安全地用于清醒的纤维支气管镜气管插管,具有稳定的血压和防止脱饱和的优点。和病人在缺氧的高风险可通过使用内窥镜面罩受益。试用注册试用注册:www.chictr.org.cn。注册号:ChiCTR-TRC-13004086。注册日期:2013年9月8日。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号